Tatsis Ourania - Insider Non-Derivative Transactions at VERTEX PHARMACEUTICALS INC / MA (VRTX) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 3, 2025, Tatsis Ourania's relationship to VERTEX PHARMACEUTICALS INC / MA (VRTX) is Officer (EVP, Chief Reg. & Quality Off.), and currently has 46,793 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other VRTX insiders.

Related Topics: SEC Topic List.
Data Source: SEC.
Tatsis Ourania - Insider Non-Derivative Transactions of VRTX Common Stock
Tatsis Ourania - Insider Non-Derivative Transactions at VRTX
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Dec 4, 2025 Sell -- (Common Stock) 4500 449.99 46793
Mar 11, 2025 Sell -- (Common Stock) 3242 499.99 51239
Mar 5, 2025 Sell -- (Common Stock) 4058 485.49 54481
Feb 28, 2025 Sell -- (Common Stock) 530 475.34 58539
Feb 27, 2025 F -- (Common Stock) 4962 479.61 59069
Feb 26, 2025 Sell -- (Common Stock) 354 480.95 64031
Feb 25, 2025 F -- (Common Stock) 3310 483.28 64385
Feb 19, 2025 Sell -- (Common Stock) 244 455.06 67695
Feb 15, 2025 F -- (Common Stock) 2293 463.46 67939
Feb 13, 2025 Acquisition -- (Common Stock) 6211 0 70232
Feb 12, 2025 Sell -- (Common Stock) 310 459.83 64021
Feb 11, 2025 F -- (Common Stock) 2143 467.98 64331
Feb 5, 2025 Acquisition -- (Common Stock) 10262 0 59360
Feb 5, 2025 Acquisition -- (Common Stock) 7114 0 66474
Jun 4, 2024 Sell -- (Common Stock) 2175 460 49098
Jun 1, 2024 Sell -- (Common Stock) 2250 445 51273
May 31, 2024 Sell -- (Common Stock) 2350 439.11 53523
Feb 27, 2024 Sell -- (Common Stock) 354 425.7 55804
Feb 24, 2024 F -- (Common Stock) 3309 431.79 56158
Feb 22, 2024 Sell -- (Common Stock) 360 421.77 59467
Feb 21, 2024 Sell -- (Common Stock) 480 420.79 59827
Feb 21, 2024 F -- (Common Stock) 3373 420.58 60307
Feb 17, 2024 F -- (Common Stock) 4499 424.01 63680
Feb 13, 2024 Sell -- (Common Stock) 314 420.24 68179
Feb 10, 2024 F -- (Common Stock) 2100 422.74 68493
Feb 8, 2024 Acquisition -- (Common Stock) 7114 0 70593
Feb 7, 2024 Acquisition -- (Common Stock) 6976 0 55613
Feb 7, 2024 Acquisition -- (Common Stock) 7866 0 63479
Aug 24, 2023 Sell -- (Common Stock) 2500 355 48637
Aug 11, 2023 Sell -- (Common Stock) 5750 345.79 51137
Feb 28, 2023 Sell -- (Common Stock) 20 289.29 56805
Feb 28, 2023 Sell -- (Common Stock) 51 288.33 56825
Feb 28, 2023 Sell -- (Common Stock) 283 287.2 56876
Feb 25, 2023 F -- (Common Stock) 3308 289.12 57159
Feb 22, 2023 Sell -- (Common Stock) 124 294.77 60467
Feb 22, 2023 Sell -- (Common Stock) 207 293.83 60591
Feb 22, 2023 Sell -- (Common Stock) 145 292.85 60798
Feb 22, 2023 Sell -- (Common Stock) 4 291.01 60943
Feb 18, 2023 F -- (Common Stock) 4498 292.85 60947
Feb 15, 2023 Sell -- (Common Stock) 51 300.58 65445
Feb 15, 2023 Sell -- (Common Stock) 135 299.6 65496
Feb 15, 2023 Sell -- (Common Stock) 43 297.98 65631
Feb 15, 2023 Sell -- (Common Stock) 20 296.48 65674
Feb 15, 2023 Sell -- (Common Stock) 71 295.89 65694
Feb 14, 2023 Sell -- (Common Stock) 11 300.79 65765
Feb 14, 2023 Sell -- (Common Stock) 64 299.88 65776
Feb 14, 2023 Sell -- (Common Stock) 120 298.98 65840
Feb 14, 2023 Sell -- (Common Stock) 78 298.11 65960
Feb 14, 2023 Sell -- (Common Stock) 2 295.84 66038
Feb 14, 2023 F -- (Common Stock) 2995 298.26 66040
Feb 11, 2023 F -- (Common Stock) 1377 294.33 69035
Feb 2, 2023 Acquisition -- (Common Stock) 6194 0 52284
Feb 2, 2023 Acquisition -- (Common Stock) 10262 0 62546
Feb 2, 2023 Acquisition -- (Common Stock) 7866 0 70412